Bao M, Zhang XS, Li ZR, Yu L, et al. Efficacy, safety and predictive biomarker of third-generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemia. Cancer 2025;131:e70166.
PMID: 41199590